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Abstract
Calibration curve is a regression model used to predict the unknown concentrations of ana-
lytes of interest based on the response of the instrument to the known standards. Some 
statistical analyses are required to choose the best model fitting to the experimental data and 
also evaluate the linearity and homoscedasticity of the calibration curve. Using an internal 
standard corrects for the loss of analyte during sample preparation and analysis provided 
that it is selected appropriately. After the best regression model is selected, the analytical 
method needs to be validated using quality control (QC) samples prepared and stored in the 
same temperature as intended for the study samples. Most of the international guidelines 
require that the parameters, including linearity, specificity, selectivity, accuracy, precision, 
lower limit of quantification (LLOQ), matrix effect and stability, be assessed during valida-
tion. Despite the highly regulated area, some challenges still exist regarding the validation 
of some analytical methods including methods when no analyte-free matrix is available.
Keywords: analytical method, calibration, linearity, regression analysis, validation
1. Introduction
Calibration curve in bioanalytical method is a linear relationship between concentration (inde-
pendent variable) and response (dependent variable) using a least squares method. This relation-
ship is built to predict the unknown concentrations of the analyte in a complicated matrix. The 
unknown samples can be from a wide range of sources: food and agricultural, pharmaceutical 
formulations, forensic and the clinical pharmacology studies. This chapter is more focused on 
the bioanalytical methods in which an analyte is measured in blood, plasma, urine or other bio-
logical matrices. However, the main concepts are applicable to the other analytical approaches.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The quality of a bioanalytical method is highly dependent on the linearity of the calibra-
tion curve [1]. A linear calibration curve is a positive indication of assay performance in a 
validated analytical range. Other characteristics of the calibration curve, including regression 
model, slope of the line, weighting and correlation coefficient, need to be carefully evaluated. 
In the following sections, each of those parameters is explained, and few practical examples 
have been used to further discuss the concepts.
After the calibration model is chosen, it is required to demonstrate that all future measure-
ments will be close to the true values of the content of the analyte in the sample. This will 
be achieved during validation of the analytical method. There are international guidelines 
for the validation of the analytical methods, which need to be followed closely in order to 
have more consistent data throughout different laboratories and increase the chance of their 
acceptability by the regulatory authorities.
2. Aims
The aim of this chapter is to discuss different aspects of linearity and relevant assumption as 
a practical guide to develop a robust analytical method in order to predict true concentrations 
of the analytes in samples.
3. Calibration curve: definitions and characteristics
3.1. Regression analysis
Regression analysis is a deterministic model, which allows predicting of the values for a 
dependent variable (Y) when an independent variable (X) is known. The model determines 
the kind of relationship between X and Y. The experimental values rarely fit the mathemati-
cal model, and there are differences between the observed and the predicted values provided 
by the model, which are called residuals (Figure 1). The sum of squared residuals needs to 
be minimised to have the best estimate of the model parameters, and it can be done using 
the “method of least squares.” The simplest regression model is the linear one in which the 
relationship between X (known without error) and Y (known with error) is a straight line, 
Y = a + bX, where a is the y-intercept and b is the slope of the line [1].
The relationship between an instrument response and the known concentrations of an analyte 
(standards), which is used as the calibration curve can be explained by a similar regression 
model. To have a robust calibration line (or curve), a series of replicates of each standard (at 
least three replicates of 6–8 expected range of concentration values) are recommended. The 
assumption for this model is that the measurement error is the same and normally distributed 
for each sample. If this assumption is not applicable, an extended or weighted least squares 
analysis will be required. The assumption regarding the measurement error must be verified 
to validate the results found. The distribution properties of the residuals are expected to be 
normal and centred on zero (Kolmogorov–Smirnov test). If the results found cannot support 
Calibration and Validation of Analytical Methods - A Sampling of Current Approaches110
this assumption, the estimated parameters using the model cannot be used, and the model 
needs to be modified, e.g. using a non-linear model which requires more standard concen-
trations compared with having a linear relationship between concentrations and instrument 
response. A linear regression model between calculated standard points and the nominal 
ones used to evaluate the quality of the fit should have a unit slope and a zero intercept. In 
case of linear calibration method, the slope should be statistically different from 0, the inter-
cept should not be statistically different from 0 and the regression coefficient should not be 
statistically different from 1. In case of having a significant non-zero intercept, the accuracy of 
the method must be demonstrated [2].
A standard 0 must be included in the calibration curve because the instrumental signal is sub-
jected to the same kind of error for all points. The signal for the standard zero should not be 
subtracted from the response values for other standards before calculating the equation of the 
regression line because it can cause imprecision during the determination of the concentration 
values for unknown samples [3].
If one of the standard points deviates greatly from the calibration curve (outlier), it can be 
removed from the equation provided that six non-zero standards remain after removing the 
outlier and inclusion of that point can cause the loss of sensitivity or it clearly biases the 
quality control (QC) results, and the back-calculated standard concentrations deviate from its 
nominal value. The poor chromatography can also be considered as a justification for remov-
ing the outlier standard [4].
In order to verify the accuracy and precision of the analytical method during the period of 
sample analysis, quality control (QC) samples are prepared and stored frozen at the same 
temperature as is intended for the storage of the study samples. The calibration curve stan-
dards are prepared by spiking the reference standard solutions to the matrix (e.g. plasma or 
urine) either freshly or by freezing and storage with QC samples [4].
Figure 1. Linear regression model in which the differences between observed and predicted values (residuals) have been 
shown.
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3.2. Weighting in linear regression
When the range in x-values is large, e.g. more than one order of magnitude, the variance of 
each data point might be quite different. However, the simple least squares method considers 
that all the y-values have equal variances. Larger deviations at larger concentrations tend to 
influence the regression line more than smaller deviations associated with smaller concentra-
tions (heteroscedasticity) leading to the inaccuracy in the lower end of the calibration range 
(see the practical example 1). A simple and effective way to counteract this situation is to use 
weighted least squares linear regression (WLSLR) [1]. WLSLR is able to reduce the lower limit 
of quantification (LLOQ) and enables a broader linear calibration range with higher accuracy 
and precision especially for bioanalytical methods.
Two most commonly used regression models, particularly for liquid chromatography tan-
dem mass spectrometry (LC-MS/MS) calibration curves, are linear and quadratic regres-
sion models using non-weighted or weighted least squares regression algorithm. To select 
the type of calibration curve and weighting, “Test and Fit” strategy is widely used due to 
its simplicity and lack of statistical analysis and causes inaccuracy in the regression model 
based on the limited set of test results. The Food and Drug Administration (FDA) guideline 
suggests that “the simplest model that adequately describes the concentration-response 
relationship should be used and selection of weighting and use of a complex regression 
equation should be justified” [5]. However, other experts suggested that a weighting should 
be used if homoscedasticity was not met for the analytical data. By neglecting the weight-
ing for analysing data with heteroscedastic distribution, a precision loss as big as one order 
of magnitude in the low concentration region of the calibration curve could happen [4].
For most immunoassay methods, the response is a non-linear function of the analyte concen-
tration, and the standard deviations (SD) of the calculated concentrations are not a constant 
function of the mean response; therefore, a weighted, non-linear least squares method is gen-
erally recommended for fitting dose-response data. The nonevidence-based weights (e.g. 1/Y 
or 1/X) are not recommended without assessment of the response-error relationship. A refer-
ence model for immunoassay data employs the four-parameter logistic (4PL) equation to fit 
the concentration-response relationship and a power-of-the-mean (POM) equation to fit the 
response-error relationship [6].
3.3. Correlation coefficient
Linearity of the calibration curve is usually expressed through the coefficient of correlation, r, 
or coefficient of determination, r2. A correlation coefficient close to unity (r = 1) is considered 
by some authors’ sufficient evidence to conclude that the calibration curve is linear. However, 
r is not an appropriate measure for the linearity. The FDA guidance for validation of ana-
lytical procedures [5] recommends that the r should be submitted when evaluating a linear 
relationship and that the linearity should be evaluated by appropriate statistical methods, e.g. 
analysis of variance (ANOVA). This guidance does not suggest that the numerical value of r 
can be used as a degree of deviation from linearity.
Other mathematical measures, including slope standard relative deviation or goodness of 
fit, can be used to evaluate the linearity [3]. Using residual plots is a simple way to check the 
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linearity. The residuals are expected to be normally distributed for a linear model, so a plot 
of them on a normal probability graph may be useful. Any curvature suggests a lack of fit 
(LOF) due to a non-linear effect. A segmented pattern indicates heteroscedasticity in data, so 
weighted regression model should be used to find the straight line for calibration [7].
A clear curved relationship between concentration and response may also have an r value close 
to one. Two statistical tests, including the lack-of-fit and Mandel’s fitting tests, are suitable for 
the validation of the linear calibration model (practical example 2 [8]). A straight-line model 
with r close to 1, but with a lack of fit, can produce significantly less accurate results than its 
curvilinear alternative. A straight-line calibration curve should always be preferred over cur-
vilinear or non-linear calibration models if equivalent results can be obtained and is easier to 
implement [8].
3.4. Slope of the curve and application in matrix effect and detection limit
Slope of the calibration curve can be used to estimate the detection limit of the assay [9]. Three 
times the standard deviation value of the response corresponding to the blank according to 
Eq. (1), obtained for seven determinations, divided by the slope of the calibration line (note 
that we are calculating the standard deviation of the concentration corresponding to the blank 
equation, and again the imprecision of the value of the slope is not taken into account) [3]:
  LOD = 3.3 ×  ( S Y  / a) . (1)
S
Y
 denotes the SD of responses, Y, for blanks or around expected LOD (limit of detection) and 
“a” for the slope of a linear calibration line. If the calibration curve is linear, “a” is constant, 
and the estimation of LOD is easy to calculate. However, when the calibration curve is not 
linear, e.g. in enzyme-linked immunosorbent assay (ELISA), the definition needs to be modi-
fied. In the case of ELISA, when there is a semilogarithmic calibration curve over a wide range 
of concentrations, the detection limit is calculated using a differential coefficient which is 
obtained using a computer programme [9].
It is assumed that a validated analytical method should have constant slope over the period 
of sample analysis. Variation in the slope might be due to the laboratory errors during sample 
preparations, change in the internal standard (IS) of working solution concentrations between 
preparations, instrument variations such as changes in mass spectrum (MS) calibrations, MS 
signal cross contributions between analyte and IS and matrix effect (ME) [10]. Although there 
is no criteria in the international guidelines to report the slope, monitoring the slope can pro-
vide valuable information regarding the quality of the sample analysis.
ME can also affect the slope of the calibration curve. Coeluting of the matrix components 
escaped during extraction may reduce the signal intensity and affect the accuracy and pre-
cision of the MS-based assays. The phenomenon is called ion suppression, and it has been 
shown that the electrospray ionisation responses of organic bases decrease with an increase 
in concentrations of other organic bases present in the matrix. The ME is especially depen-
dent on the degree of sample clean-up and chromatographic separation of the analyte. When 
developing high-throughput assays using a short run time, a careful assessment of the ME 
and ion suppression is necessary [11].
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3.5. Internal standard (IS)
IS is a chemical substance that is added in equal amounts to all samples, and it changes the 
way that calibration curve is prepared. Instead of analyte response, the ratio of the analyte 
to the IS signal versus the analyte concentration is plotted. The benefits of adding the IS are 
to correct or compensate analyte losses during sample preparation including transfer loss, 
adsorption loss, evaporation loss and variation in injection volume and in MS response due to 
ion suppression or enhancement (ME).
The IS must have similar physicochemical properties and show similar behaviour to the ana-
lyte when extracted or run through the analytical column or detection in the analytical system. 
An external standard also behaves similarly with the analyte, but it is run alone at different 
concentrations, so a standard curve can be generated. External standards do not correct for 
losses that may occur during preparation of the sample. Using IS is usually more effective due 
to lower measurement uncertainty and therefore is more common in analytical chemistry [12].
Two common types of ISs are used: structural analogues and stable isotope-labelled (SIL) ISs 
or isotope dilution mass spectrometry (IDMS). SIL ISs are more effective. To reduce the inter-
ferences between IS and analyte, SIL IS molecular weight is preferred to be ideally 4 or 5 Da 
higher than that of the analyte. Labelled SIL ISs with 13C and/or 15N are usually superior to 
those labelled with deuterium (2H, D or d) in terms of performance; however, the synthesis of 
deuterated ISs is easier and cheaper. The location of stable isotope atoms should be in a way 
that deuterium-hydrogen exchange is minimised during sample preparation.
A structural analogue of the analyte can be used if SIL ISs are not available or expensive. 
In this case, the IS should preferably have key structure and functionalities (e.g. –COOH, 
–SO
2
, NH
2
, halogen and heteroatoms) of the analyte with difference only being C–H moieties 
(length and/or position). Modifications in key chemical structure and/or functionalities cause 
significant differences in ionisation pattern and even extraction recovery. The IS should not 
be similar or converted to any in vivo biotransformed products of the analyte (e.g. hydroxyl-
ated or N-dealkylation metabolites). An appropriate structural analogue IS can be selected 
from the same therapeutic class as the analyte or by key chemical structure and preferably a 
compound that is not very commonly prescribed because those compounds may be present in 
pooled blank plasmas used for preparation of the calibrators and QCs. Other parameters for 
choosing a right structure analogue IS are physicochemical properties, such as log D (hydro-
phobicity), pKa and water solubility. For selection of the IS, it may be difficult to have a com-
pound to track the analyte of interest in all the three distinctive stages of LC-MS bioanalysis, 
sample preparation (extraction), chromatographic separation and mass spectrometric detec-
tion. The IS should be chosen depending on which step is more critical. For example, when 
the extracts of samples contain coeluting matrix components that cause ion suppression, then 
tracking the analyte during MS detection to avoid or minimise ME becomes more important. 
The choice of IS is also depending on the extraction method. Tracking an analyte during 
a simple protein precipitation procedure would be less stringent than that for liquid-liquid 
extraction (LLE) or solid-phase extraction (SPE) method [13].
It is possible to develop an assay without using any IS, for example, in early drug discovery 
stage or when clean extracts are used. In this case, ECHO peak technique can be used where 
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the analyte is used as its own IS. In this method, after the injection of the sample contain-
ing the analyte of interest, a standard solution is also injected, which result in two peaks for 
the analyte, one from the sample and the other from the standard solution with constant 
concentration (an echo peak). By using their response ratio for quantitation, the ME might 
be compensated for because the two peaks are affected by the coeluted matrix components 
similarly [13].
There is no general rule for choosing the IS concentrations. However, the accuracy and precision 
of the method may be affected if an inappropriate IS concentration is used. As shown in practical 
example 3, reducing the concentration of IS can lead to the increasingly non-linear calibration 
curve due to chemical impurity in the reference standard or because of isotope interferences.
When choosing the IS and its concentration, the magnitude of the cross signal contribution 
between the analyte and IS should be considered. The IS interference signal due to its impu-
rity or isotope interferences should be equal or less than 20% of the LLOQ response and 
5% of the IS response for IS-to-analyte and analyte-to-IS contributions, respectively [14]. The 
minimum IS concentration required (CIS-Min) and the maximum IS concentration allowed 
(CIS-Max) can be calculated using Eqs. (2 and 3):
  CIS-Min = m × ULOQ / 5 . (2)
  CIS-Max = 20 × LLOQ / n . (3)
where m and n represent the % of cross signal contributions from analyte to IS and IS to ana-
lyte, respectively. As an example, if the cross signal contribution from analyte to IS is 2.5%, the 
minimum IS concentration calculated accordingly is 50% of the ULOQ. A high IS concentra-
tion might be useful in reducing a systemic error in the analysis of unknown samples. If the IS 
coelutes more closely to the analyte, it will be more effective in minimising ME.
In some cases, the analyte signal might be suppressed by the coeluting IS signal, and therefore 
the IS concentration must be kept low to maintain a low detection limit. However, it might be 
required to increase the IS concentration when the analyte suppresses the IS signal.
IS should be added as early as possible to compensate for the variabilities during sample 
preparation and analysis; however, if the IS structure is not very close to the analyte, it can 
be used to reduce the variabilities due to the ion suppression or enhancement only and not 
sample extraction [13].
3.6. Linearity when no analyte-free matrix exists
For making calibrators and QCs, an analyte-free matrix is required. The presence of unknown 
amount of the analyte in the matrix makes the quantification difficult, and different approaches 
have been used to overcome the problem including using stripped matrices (filtration on acti-
vated charcoal-dextran or dialysis), substitute matrices (e.g. neat solutions, artificial matrices, 
human serum albumin or 0.9% sodium chloride) or diluted matrices. If the actual matrix is 
used, various methods are followed including, background subtraction, or the standard addi-
tion method [3, 15].
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One of the approaches for validation of the assay is to determine the accuracy throughout the 
validation step, using the biological matrix containing the endogenous compound to prepare 
the standard curves and all pools of six or more assays of each QC sample [3]. The amount of 
the analyte in the matrix (C
basal
) can be computed using a calibration curve in the substitute 
matrix, and the concentration of the analyte in the QC can be calculated by subtracting the 
C
basal
 from the calculated one as follows, C
real
 = C
found
 – C
basal
, in which C
found
 is the concentration 
of the analyte in the QCs calculated against a calibration curve in the substitute matrix and 
C
real
 is the corrected concentration [3]. When using this approach, the LLOQ of the method 
cannot be smaller than the endogenous concentrations of the analyte in the matrix, and there-
fore a lot of blank matrices need to be screened to find the suitable one.
Alternatively, the endogenous concentration of the analyte in the matrix can be subtracted from 
the added concentrations and uses the subtracted concentrations to build the calibration curve. 
Using the actual biological matrix for making the calibrators and QCs reduces the recovery and 
matrix effects between samples and calibrators. Again, the limitation of this method is that the 
increase in background peak area after spiking with standards has to be at least 15–20% of the 
background peak area, and the LLOQ is limited by the endogenous background concentration 
even if much lower concentrations can be detected by the method. Another difficulty is when 
multiple analytes with different endogenous compounds need to be quantified [15].
Alternatively, the background concentration in the blank matrices can be lowered by dilution 
of the blank matrices before spiking with standards. However, by diluting the matrix, the 
composition of the matrices in the study samples versus calibration curve is different leading 
to different recoveries of the analytes. Therefore, the extraction recoveries of analytes between 
the matrix and diluted matrix should be determined before using this method [15].
3.6.1. Surrogate matrices
Surrogate matrices can vary widely from a simplest form, mobile-phase solvents (neat) or 
pure water to a synthetic polymer-based solution. Some biological matrices, e.g. cerebrospi-
nal fluid or tears, are difficult to obtain. The surrogate matrix should simulate the authentic 
matrix in terms of composition, salt content, analyte solubility, recovery and ME. For exam-
ple, phosphate-buffered saline (PBS) or bovine serum albumin (BSA) in PBS (20–80 g/L) has 
the similar protein and ionic strength as human plasma.
To use neat solutions as surrogate matrices, extraction recovery and ME are required to be com 
parable with the original matrix. For example, thromboxane B2 and 12(S)-hydroxyeicosatetrae- 
noic acid were quantified in human serum using mixture of water/methanol/acetonitrile 
(80:10:10, v/v/v) as a surrogate matrix, and the ME and recoveries of the analytes were dem-
onstrated to be comparable.
3.6.2. Stripped matrices
Biological matrices can be stripped from particular endogenous components to generate ana-
lyte-free surrogate matrices. Adding activated charcoal, for example, can adsorb and remove 
the analyte from the matrix, but the charcoal must effectively remove from the matrix before 
Calibration and Validation of Analytical Methods - A Sampling of Current Approaches116
spiking the analyte. Some analytes, e.g. homocysteine, cannot be removed by the charcoal and 
also the composition of the matrix may change or cause batch-to-batch variation after adding 
the charcoal leading to the altered analyte recovery and ME. Some light-sensitive analytes 
can be decomposed by heat or exposing to the light and therefore removed from the matrix.
3.6.3. Method of standard addition
In the standard addition method, every study sample is divided into aliquots of equal vol-
umes, and the aliquots are spiked with known and varying amounts of the analyte to build the 
calibration curve. The sample concentration is then calculated as the negative x-intercept of the 
calibration line. This method is very accurate because it allows direct quantitation of endog-
enous analytes without manual subtraction of background peak areas. The disadvantage of 
the method is that it requires a large amount of sample and is very time-consuming and labour 
intensive. Examples of using this method when the analyte-free matrices are not available 
include measuring abscisic acid, a phytohormone from plant leaves and the emission of poly-
cyclic aromatic hydrocarbons from petroleum refineries. Standard addition can also be used 
when some matrix components produce MS signals that interfere with the analytes of interest.
We have used this method by some modifications to measure homocysteine and pyridoxal 
5-phosphate in samples of human serum and whole blood, respectively [16, 17]. The matrix 
was first spiked with different concentrations of the analytes, and the endogenous concen-
trations of the analytes were estimated using the negative x-intercept of the calibration line. 
Then, the endogenous concentrations were added to the spiked concentrations, and new cali-
bration curves with real concentrations were constructed (practical example 4). QCs were pre-
pared in both actual and surrogate matrices, and the sample volume reduced to only 20 μL to 
minimise the matrix effect.
3.7. Validation
All the developed analytical methods need to be validated to make sure that each mea-
surement of the content of the analyte in the sample in routine analysis is close to the true 
values [7]. There are international guidelines for validation of the analytical methods includ-
ing FDA [6], European Medicines Agency (EMA) [14], International Union of the Pure and 
Applied Chemistry (IUPAC) [18] and Association of Official Analytical Chemists (AOAC) 
International. The major parameters need to be validated including linearity, accuracy, preci-
sion, specificity, selectivity, sensitivity, ME and stability testing.
3.7.1. Selectivity and specificity
Selectivity is the ability of a method to determine a particular analyte in a complex matrix 
without interference from other ingredients of the matrix. Specificity, however, is the ultimate 
in selectivity, and it means that no interference is expected to occur, but these two terms are 
used interchangeably in the literature. If a method has specificity for an analyte, it means that 
either you have it or you do not. Selectivity can be graded as low, high, partial, good or bad, 
but the selectivity refers to 100% selectivity (or 0% interference) [19].
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Selectivity can be calculated by comparing the chromatograms obtained after injection of a 
blank sample with and without the analyte or analytical solutions and with and without the 
matrix components.
3.7.2. Accuracy
Accuracy (or trueness or bias) is the most important aspect of validation and should be 
addressed in any analytical method. Accuracy shows the extent of agreement between the 
experimental value (calculated from replicate measurements) and the nominal (reference) 
values. Accuracy is a measurement of the systematic errors affecting the method. To estimate 
the accuracy of a method, the analyte is measured in comparison with a reference material or 
by spiking known amount of analyte in the blank matrix (QC samples) and calculating the 
percentage of recovery from the matrix. It can also be estimated using the comparison of the 
results from the method by a reference method [19].
The guideline for validation of analytical methods by the EMA [14] recommends checking the 
accuracy within run and between runs by analysing a minimum of five samples per four QC 
levels (LLOQ, low, medium and high) as a representative of the whole analytical range in at 
least two different days. The accuracy needs to be reported as the percentage of the nominal 
concentrations and the mean concentration should be within 15% of the nominal values for all 
QC levels, except LLOQ, which should be within 20% of the nominal values [14].
3.7.3. Precision
The term precision is defined as the closeness of repeated individual measurements of an 
analyte under specified conditions. This term is demonstrating the repeatability and repro-
ducibility of the method and expressed as the coefficient of variation (CV). Precision should 
be measured for LLOQ, low, medium and high QC samples in the same run that accuracy is 
testing. The acceptance criteria are also similar to the accuracy evaluation [14, 19].
3.7.4. Uncertainty
To make sure that a method is correctly fit for the purpose of measurement, “uncertainty” of 
the method is required to be evaluated [7].
A detailed list of all possible sources of uncertainty needs to be prepared. A preliminary study 
may identify the most significant sources of uncertainty. Typically, the two sources of uncer-
tainties are Type A or random error and Type B or systematic error. Random error is caused 
by unpredictable variations and gives rise to variations in repeated observations. The random 
error can generally be minimised by increasing the number of observations. Systematic error, 
however, is a type of errors, which remain constant, or its variation is predictable and therefore 
independent of the number of observations. The result should be corrected for all recognised 
significant systematic errors. The steps involved in uncertainty estimation are identification 
of uncertainty sources, quantification of uncertainty components and calculation of combined 
and expanded uncertainty. The main sources of uncertainity are sampling, environmental 
conditions, method validation, instruments, weighting and dilutions, reference materials, 
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chemicals and in high-performance liquid chromatography (HPLC) are repeatability of peak 
area, dilutions factors, reference materials and sampling. Sampling, calibration and repeat-
ability were the most significant sources, which affect combined uncertainty [20].
3.7.5. LOD and LLOQ
The LOD is generally defined as the lowest amount of an analyte in a sample that can be 
detected by a particular analytical method. LOD is usually evaluated using the calculation of 
the signal/noise relationship considering the assumption that data normality, homoscedastic-
ity and independency of residuals are met. The signal-to-noise ratio is determined by compar-
ing the analytical signals at known low concentrations compared with those of blank sample 
up to a concentration that produces a signal equivalent to three times the standard deviation 
of the blank sample [19]. Determination of the LOD is not necessary during the validation, 
because the assay may have high variability in that level.
On the other hand, the lowest concentration of an analyte in a sample, which can be reliably 
quantified is defined as the LLOQ. The analyte signal at the LLOQ level should be at least five 
times the signal of blank sample and the accuracy and precision within 20% of the nominal 
concentrations. The LLOQ should be selected based on the expected concentrations in the 
study. For example, for bioequivalence studies the LLOQ should not be higher than 5% of the 
maximum concentration of the analyte in the samples (Cmax) [14].
3.7.6. Matrix effect (ME)
ME measurement is necessary for validation when the analytical method uses mass spectrom-
etry as the detector due to the ion suppression or induction caused by the matrix components. 
The ME evaluation required spiking the analyte (at low and high concentrations) in six lots 
of matrix obtained from individual donors. First, the ratio of the peak area in the presence of 
matrix to the peak area in the absence of the matrix is calculated to achieve the matrix factor 
(MF), followed by the calculation of the IS normalised MF by dividing the MF of the analyte 
of interests by the MF of the IS. The CV of the IS-normalised MF is calculated from the six lots 
of the matrix and should be ≤15% (practical example 5). In some cases that this method is not 
practical (e.g. online sample preparation), the variability of the response should be assessed 
by analysing at least six lots of matrix spiked at low and high levels. The overall CV should 
not be greater than 15%. The ME is also recommended to be tested in haemolysed, hyperlipi-
daemic matrices or plasma collected from renally or hepatically impaired patients depending 
on the target population of the study [14].
3.7.7. Stability
Stability testing must be planned based on the conditions applied to the samples during pro-
cessing. The stability is tested using spiked concentrations of the analyte to the matrix at low 
and high QC levels (six replicates at two levels are generally sufficient). Short-term stabil-
ity at room temperature (2–8 h depending on the latest period of time required for sample 
 processing), long-term stability at storage temperature (e.g. at −20°C or −80°C), freeze and 
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Concentration (ng/mL) Area ratio Accuracy
(no weighting)
Accuracy
(1/x weighting)
0 0.002 0 0
6 0.006 125 92.3
18 0.019 104 94.1
37.5 0.400 98.5 94.1
75 0.836 101 99.3
300 3.320 98.5 98.9
480 5.290 97.8 98.5
600 6.890 102 103
Table 1. Increasing the accuracy of the lower end of the calibration curve by applying the weighing.
thaw and stock solution stabilities are the most common tests. The stability of QC samples 
are analysed against a freshly prepared calibration curve, and the calculated concentrations 
should be within 15% of the nominal concentrations. The stability of processed samples in the 
autosampler temperature also determines how long samples can be stored in the autosampler 
without the analyte been degraded [14]. Any other variation during sample processing which 
can potentially affect the stability of the analyte of interest needs to be tested during validation.
4. Practical examples
4.1. Practical example 1: impact of weighting
See Table 1.
4.2. Practical example 2: linearity assessment
In Table 2, it shows that the linear regression model (LRM) must systemically be rejected at the 
95% confidence level (Fcrit,95% = 4.53) for lack-of-fit test and at 99% confidence level (Fcrit,99% = 10.56) for Mandel’s fitting test. Thus, despite the fact that r and quality coefficient (QC) are greater 
than 0.997 and lower than 5%, respectively, the linearity of the calibration lines was rejected 
based on the F-tests. So, the r is not a good measure of the linearity assessment. Even with a QC 
value less than 3%, the LRM is rejected at the 95% confidence level (Table 2). Alternatively, the 
residual plots give useful information to validate the chosen regression model.
The residual plot can be used to check if the principle assumptions, i.e. normality of the 
residuals and homoscedasticity, are met when evaluating the goodness of fit of the regres-
sion model. The U-shaped residual plot usually shows that a curvilinear regression model is 
a better fit than an LRM. In order to correct the non-linearity, a quadratic curvilinear function 
(f(x) = a + bx + cx2) can be chosen. The “lack of fit” tests for the quadratic regression model 
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(QRM) are summarised in Table 2. The test for lack of fit indicates that this QRM fits the 
calibration data at 99% confidence level in all cases except one. To check the suitability of the 
order of polynomial regression model, the significance of the second-order coefficient needs 
to be estimated. The P-value on the second-order coefficient, shown in Table 2, is systemically 
smaller than 1%, and therefore a lower order model should not be considered. Moreover, 
residual plots (Figure 2) were constructed for the QRM, and the residuals were randomly scat-
tered within a horizontal band around the centre line. Therefore, the QRM was selected as the 
reference model. It is noted that an increase of the variance is observed at higher concentra-
tions [8].
As a summary, in this example, a linear model with r > 0.997 and QC < 5% but with lack of fit 
(LOF) yielded predicted values for a mid-scale calibration standard that significantly differ 
from the nominal ones. The accuracy was overestimated, while the precision on the results 
was comparable in both LRM and QRM [8].
4.3. Practical example 3: IS concentration and the linearity
The role of IS concentration on the linearity of the calibration curve has been demonstrated by 
Tan et al. [13]. They presented a case in which decreasing concentration of the IS from 100% 
Linear regression model Quadratic regression model
LOF Mandel’s test value QC (%) r LOF P-value on second-order coefficient
11.08 51.46 3.93 0.9982 0.63 0.0000
19.42 56.84 4.23 0.9978 1.58 0.0000
7.13 26.29 3.67 0.9985 0.94 0.0006
6.99 37.73 3.79 0.9984 0.18 0.0002
11.43 58.21 4.03 0.9981 0.31 0.0000
29.91 53.02 3.53 0.9986 4.08 0.0000
49.80 71.07 3.76 0.9984 5.69 0.0000
23.77 73.86 3.19 0.9989 1.66 0.0000
31.95 63.37 3.24 0.9988 3.55 0.0000
7.49 33.50 2.92 0.9991 0.54 0.0003
9.99 55.19 3.95 0.9983 0.15 0.0000
10.71 28.65 4.70 0.9975 1.89 0.0005
25.21 79.60 3.34 0.9987 1.62 0.0000
13.16 35.74 3.37 0.9987 1.93 0.0002
For the quadratic regression model, the F-value of the lack-of-fit test and the P-value for testing significance of the 
second-order coefficient for the quadratic regression model are represented. The significance value at the 95% confidence 
level is underlined (reproduced from Van Loco et al. [8] with permission from Springer-Verlag).
Table 2. The F-value of the lack-of-fit (LOF) test and Mandel’s fitting test is compared with the quality coefficient for 
several linear calibration lines of Cd.
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to 5% ULOQ made the calibration curve non-linear. In that case, the cross-contribution from 
the analyte to the IS is equivalent to 5% of the concentration of the analyte. The cross-signal 
contribution from the analyte to the IS is either due to the isotope interference or chemical 
impurity in reference standard [13].
4.4. Practical example 4: method of standard addition for homocysteine calibration 
curve
Table 3 shows the calculated calibration curve data for homocysteine standard solutions 
spiked into a pooled human serum.
To estimate the endogenous concentrations of homocysteine in the sample of pooled human 
serum, the negative x-intercept of the curve is calculated:
  x =  − 0.262 _______ 0.000598 = 438 ng / mL . (4)
Figure 2. Plots of residuals for (a) the linear regression model (LRM) and (b) the quadratic regression model (QRM) 
versus predicted values (adopted from Van Loco et al. [8] with permission from Springer-Verlag).
Spiked concentrations (ng/mL) Calculated concentration (ng/mL)
0 N/A
50 30.87
600 632.76
1100 1107.05
1600 1652.48
2100 2167.02
2600 2584.02
3100 3031.75
Regression equation: y = 0.000598 x + 0.262.
Table 3. Homocysteine calibration curve: the x-axis is representing the spiked concentrations.
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Then, the nominated concentration is changed to the spiked + endogenous concentrations, 
and a new calibration is constructed (Table 4).
Now, by comparing the detector response for the unknown samples with the second calibra-
tion curve, the unknown sample concentrations can be calculated.
4.5. Practical example 5: ME calculations
Table 5 is representing the analyte peak area spiked in six different lots of human plasma. The 
MF has been calculated by dividing the area of analyte (or IS) in each matrix to the average peak 
area of the analyte (or IS) in the pure solutions. The IS-normalised MF is the ratio of the MF for the 
Spiked + endogenous concentration (ng/mL) Calculated concentration (ng/mL)
0 + 438 = 438 381.51
50 + 438 = 488 469.28
600 + 438 = 1038 1071.34
1100 + 438 = 1538 1545.77
1600 + 438 = 2038 2091.35
2100 + 438 = 2538 2606.98
2600 + 438 = 3038 3023.15
3100 + 438 = 3538 3471.01
Regression equation: y = 0.000598 x – 0.000762.
Table 4. Homocysteine calibration curve: The x-axis is representing the spiked + endogenous concentrations.
Analyte of interest IS IS-normalised MF
Peak area Matrix 
factor
Peak area Matrix 
factor
Spiked Pure (mean of 
three replicates)
Spiked Pure (mean of three 
replicates)
1,095,000 1,210,000 0.905 4,320,000 6,343,333 0.681 1.33
1,050,000 0.868 6,240,000 0.984 0.882
1,110,000 0.917 5,780,000 0.911 1.01
1,120,000 0.926 5,660,000 0.892 1.04
1,100,000 0.909 5,770,000 0.910 0.999
1,130,000 0.934 5,170,000 0.815 1.15
Mean 1.07
SD 0.154
CV% 14.4
Table 5. Calculation of ME.
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analyte to the MF for the IS. The CV% in this example was 14.4%, which is within the acceptance 
limit for the matrix effect by the EMA guideline for validation of bioanalytical methods [14].
5. Key results
• Calibration curve is a regression model between an known concentration of an analyte and 
the response from an instrument enabling the estimation of the concentration of the analyte 
in an unknown sample.
• Weighted least squares linear regression (WLSLR) is necessary when the standard devia-
tions across the standard range are not consistent. Weighting improves the sensitivity and 
accuracy of the lower end of the calibration range.
• Coefficient of correlation is not a suitable measure for the linearity of the calibration curve, 
and the linearity should be evaluated using an appropriate statistical analysis.
• Stable isotope-labelled compounds are the most preferable internal standards. However, 
carefully chosen structural analogues with similar functional groups and physicochemical 
properties can contribute to generation of comparable analytical methods.
• The concentration of the internal standard may affect the linearity of the calibration curve 
due to the cross signal contribution between the analyte and the internal standards.
• When an analyte-free matrix does not exist, the amount of endogenous analyte in the matrix can 
be estimated using the negative x-intercept of the regression equation and adding this value to 
the spiked concentrations of the analyte to calculate the actual concentrations of each standard.
• During validation of an analytical method, selectivity, specificity, accuracy, precision, un-
certainty, LLOQ, matrix effect and stability are the minimum criteria to be evaluated.
Abbreviations
4PL Four-parameter logistic
ANOVA Analysis of variance
BSA Bovine serum albumin
CIS-Max Maximum IS concentration
CIS-Min Minimum IS concentration
CV Coefficient of variation
ELISA Enzyme-linked immunosorbent assay
EMA European Medicines Agency
FDA Food and Drug Administration
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HPLC High-performance liquid chromatography
IDMS Isotope dilution mass spectrometry
IS Internal standard
IUPAC International Union of Pure and Applied Chemistry
LC–MS/MS Liquid chromatography tandem mass spectrometry
LLE Liquid–liquid extraction
LLOQ Lower limit of quantification
LOD Limit of detection
LOF Lack of fit
LRM Linear regression model
ME Matrix effect
MF Matrix factor
MS Mass spectrometry
PBS Phosphate buffer saline
POM Power of the mean
QC Quality control
QRM Quadratic regression model
SD Standard deviation
SD Standard deviation
SIL Stable isotope labelled
SPE Solid-phase extraction
ULOQ Upper limit of quantification
WLSLR Weighted least squares linear regression
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